Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 825
  • Home
  • Print this page
  • Email this page
Year : 2018  |  Volume : 131  |  Issue : 8  |  Page : 939-944

Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion

1 Department of Gynecological Oncology, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai 200030, China
2 Department of Pathology, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai 200030, China

Correspondence Address:
Dr. Yu-Dong Wang
Department of Gynecological Oncology, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai 200030, China
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0366-6999.229896

Rights and Permissions

Background: Promoter methylation of MGMT and C13ORF18 has been confirmed as a potential biomarker for early diagnosis of cervical cancer. The aim of this study was to evaluate the performance of MGMT and C13ORF18 promoter methylation for triage of cytology screening samples and explore the potential mechanism. Methods: Methylation-sensitive high-resolution melting was used to detect promoter methylation of MGMT and C13ORF18 in 124 cervical samples. High-risk human papillomavirus (HR-HPV) was detected by the Digene Hybrid Capture 2®. Gene methylation frequencies in relation to cervical intraepithelial neoplasia (CIN) were analyzed. Frequencies were compared by Chi-square tests. The expression of gene biomarkers and methylation regulators was analyzed by immunohistochemical staining, real-time fluorescence quantitative polymerase chain reaction, and Western blot. Results: For triage of low-grade squamous intraepithelial lesion (LSIL), gene methylation increased specificity from 4.0% of HR-HPV detection to 30.8% of MGMT (χ2 = 9.873, P = 0.002) and to 50.0% of C13ORF18 (χ2 = 21.814, P = 0.001). For triage of atypical squamous cells of undetermined significance, HR-HPV detection had higher positive predictive value of 54.8%. Either MGMT or C13ORF18 methylation combined with HR-HPV increased the negative predictive value to 100.0% (χ2 = 9.757, P = 0.002). There was no relationship between MGMT and C13ORF18 expression and DNA methylation (χ2 = 0.776, P = 0.379 and χ2 = 1.411, P = 0.235, respectively). MBD2 protein level in cervical cancer was relatively lower than normal cervical tissue (t = 4.11, P = 0.006). Conclusions: HR-HPV detection is the cornerstone for triage setting of CIN. Promoter methylation of MGMT and C13ORF18 plays a limited role in triage of LSIL. Promoter methylation of both genes may not be the causes of gene silence.


 Abstract in Chinese



结果:对低级别宫颈上皮内病变(low-grade squamous intraepithelial lesion,LSIL)的分流,高危HPV检测的特异性为4.0%,MGMT甲基化将诊断高级别病变的特异性提高至30.8% (X2 = 9.873, P = 0.002),C13ORF18甲基化将特异性提高至50.0% (X2 = 21.814, P = 0.001). 对不能明确意义的非典型鳞状细胞(atypical squamous cells of undetermined significance,ASCUS)的分流,高危HPV检测具有较高的阳性预测值(54.8%),MGMT或C13ORF18甲基化联合高危HPV检测均可将阴性预测值显著提高至100.0% (X2 = 9.757, P = 0.002)。MGMTC13ORF18甲基化与该基因表达无关(X2 = 0.776, P = 0.379;X2 = 1.411, P = 0.235)。宫颈癌组织MBD2蛋白表达显著低于正常宫颈组织 (t = 4.11, P = 0.006)。

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded118    
    Comments [Add]    

Recommend this journal